The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Third-line salvage chemotherapy for recurrent cervical cancer.
D. B. Manders
No relevant relationships to disclose
S. C. Purinton
No relevant relationships to disclose
J. Lea
No relevant relationships to disclose
D. S. Miller
No relevant relationships to disclose
S. M. Kehoe
No relevant relationships to disclose
D. L. Richardson
No relevant relationships to disclose